Stocks vs. Options: Which generates better returns?
Plug in your stock idea to find options trades offering a potentially better ROI.
NEW TO OPTIONS?
Visit our New to Options page to learn more.
Find out more »
Jud Pyle looks at Abbott Laboratories (ABT). Competitors include MRK and SNY.
Jud Pyle is the Chief Investment Strategist for Options News Network. After four years with SBC Warburg, he joined PEAK6 Investments as an equity options trader and chief risk officer. January 12, 2009 10:45 EST Related Symbols: ABT
ABT: $50.59 down $0.5800 or 1.13% volume: 1.23 million shares
May09 47.50 Puts: volume over 3000, trading last: $3.05 bid: $3.00 ask: $3.20 OI: 687
Straddle: Feb09 50.00 trading $4.8750 price over strike: 9.7500%
Prev. Day Straddle: Feb09 50.00 trading $5.0750 price over strike: 10.1500%
BuyWrite: Aug09 52.50 Calls Yielding 8.10% call: $4.10
Prev. Day BuyWrite: Aug09 52.50 Calls Yielding 8.60% call: $4.35
Two Traders, One Strategy Steve and Jared take a look at risk management strategies on the OH platform.
Navigating OptionsHouse Get to know the OH platform and all the tools you have at your disposal.